Authors:
RIZVI NA
MARSHALL JL
NESS E
YEO J
GILL GM
TRUGLIA JA
LOEWEN GR
JAUNAKAIS D
ULM EH
HAWKINS MJ
Citation: Na. Rizvi et al., PHASE-I STUDY OF 9-CIS-RETINOIC ACID (ALRT1057 CAPSULES) IN ADULTS WITH ADVANCED CANCER, Clinical cancer research, 4(6), 1998, pp. 1437-1442
Citation: Sr. Howell et al., EFFECTS OF RETINOID TREATMENT OF RATS ON HEPATIC-MICROSOMAL METABOLISM AND CYTOCHROMES P450 - CORRELATION BETWEEN RETINOIC ACID RECEPTOR RETINOID-X-RECEPTOR SELECTIVITY AND EFFECTS ON METABOLIC ENZYMES, Drug metabolism and disposition, 26(3), 1998, pp. 234-239
Authors:
MILLER VA
RIGAS JR
BENEDETTI FM
VERRET AL
TONG WP
KRIS MG
GILL GM
LOEWEN GR
TRUGLIA JA
ULM EH
WARRELL RP
Citation: Va. Miller et al., INITIAL CLINICAL-TRIAL OF THE RETINOID RECEPTOR PAN AGONIST 9-CIS RETINOIC ACID, Clinical cancer research, 2(3), 1996, pp. 471-475
Authors:
SHIRLEY MA
BENNANI YL
BOEHM MF
BREAU AP
PATHIRANA C
ULM EH
Citation: Ma. Shirley et al., OXIDATIVE AND REDUCTIVE METABOLISM OF 9-CIS-RETINOIC ACID IN THE RAT - IDENTIFICATION OF 13,14-DIHYDRO-9-CIS-RETINOIC ACID AND ITS TAURINE CONJUGATE, Drug metabolism and disposition, 24(3), 1996, pp. 293-302
Authors:
HALPIN RA
ULM EH
TILL AE
KARI PH
VYAS KP
HUNNINGHAKE DB
DUGGAN DE
Citation: Ra. Halpin et al., BIOTRANSFORMATION OF LOVASTATIN .5. SPECIES-DIFFERENCES IN IN-VIVO METABOLITE PROFILES OF MOUSE, RAT, DOG, AND HUMAN, Drug metabolism and disposition, 21(6), 1993, pp. 1003-1011